NCT06374914View on ClinicalTrials.gov

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

April 9, 2026

Study Completion Date

April 9, 2026

Conditions
Bladder CancerBCGGemcitabineDocetaxelIntravesical Instillation
Interventions
DRUG

Intravesical Solution

Alkalinization of urine 1 day before the procedure Emptying the bladder with a catheter before the procedure mixing 1000 mg gemcitabine in 50 ml saline 90 minutes after administration 37.5 mg docetaxel mixed 120 minutes after administration in 50 ml saline maintanence if there is a 6 week induction response

Trial Locations (1)

35330

Dokuz Eylul University Faculty of Medicine Department of Urology, Izmir

All Listed Sponsors
lead

Dokuz Eylul University

OTHER

NCT06374914 - Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients | Biotech Hunter | Biotech Hunter